Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage
暂无分享,去创建一个
Mengyao Sun | Ping Li | Shasha Zhang | Bing Chen | Chao-wei Li | Jianwei Dong | Zhuo Li | J. Dong
[1] Nan Ye,et al. Clinicopathologic characteristic and prognosis in idiopathic membranous nephropathy patients with focal segmental sclerosis lesion , 2021, Medicine.
[2] Yan Zhang,et al. Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody , 2020, PeerJ.
[3] Ying Xu,et al. Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis , 2019, BMC Nephrology.
[4] Jin Zhang,et al. Urine markers of renal tubular injury in idiopathic membranous nephropathy: A cross sectional study. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[5] L. Lv,et al. Renal tubule injury: a driving force toward chronic kidney disease. , 2018, Kidney international.
[6] V. Jha,et al. Primary membranous nephropathy in adolescence: A prospective study , 2017, Nephrology.
[7] W. Couser. Primary Membranous Nephropathy. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[8] S. Karnik,et al. Clinicopathological Analysis of Glomerular Disease of Adult Onset Nephrotic Syndrome in an Indian Cohort- A Retrospective Study. , 2017, Journal of clinical and diagnostic research : JCDR.
[9] Issue Information , 2017 .
[10] Bo Zhang,et al. Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point , 2015, Biomedical reports.
[11] G. Mircescu,et al. Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy , 2015, BioMed research international.
[12] H. Debiec,et al. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care , 2015, The Lancet.
[13] Xiangmei Chen,et al. Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function , 2014, JN. Journal of Nephrology (Milano. 1992).
[14] C. Zeng,et al. Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population. , 2013, Clinical nephrology.
[15] N. Chen,et al. Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial. , 2013, Contributions to nephrology.
[16] Jai Radhakrishnan,et al. Notice , 2012, Kidney International Supplements.
[17] B. Kasiske,et al. KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .
[18] David M. Beck,et al. Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy , 2011 .
[19] T. Taguchi,et al. [Pathology of membranous nephropathy]. , 2011, Nihon Jinzo Gakkai shi.
[20] G. Fernández-Juárez,et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.
[21] S. Agarwal,et al. Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clinico-pathological and stereological study. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] K. Sud,et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.
[23] J. Scholey,et al. Idiopathic membranous nephropathy: definition and relevance of a partial remission. , 2004, Kidney international.
[24] N. Yorioka,et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. , 2004, Kidney international.
[25] D. Cattran,et al. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] Joseph V. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.
[27] M. Mihatsch,et al. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. , 1992, The New England journal of medicine.
[28] R. Bader,et al. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. , 1981, Clinical nephrology.
[29] S. Mackensen,et al. The role of the interstitium of the renal cortex in renal disease. , 1979, Contributions to nephrology.
[30] H. D. de Wardener,et al. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. , 1968, Lancet.